Rhythm Biosciences Ltd. announced a Board and Management restructure to better reflect the Company's current and near-term operating structure. The changes announced are effective 1 December 2021. Mr. Otto Buttula moves to the role of Executive Chairman to formalise his added executive involvement in supporting the Company's commercialisation pathway. Further, the Board welcomed the appointment of Mr. Glenn Gilbert to the Board as Managing Director, recognising his consistently strong performance as Chief Executive Officer.